Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase 4 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 301 Paclitaxel 206 Carboplatin 199 Gemcitabine 173 Cisplatin 138 Docetaxel 137 Cyclophosphamide 135 Nivolumab 129 Bevacizumab 118 Injections 111 fludarabine 95 atezolizumab 91 Pemetrexed 90 Dexamethasone 90 Cetuximab 90 Fluorouracil 84 Irinotecan 77 Rituximab 72 Capecitabine 72 venetoclax 70 Azacitidine 70 130-nm albumin-bound paclitaxel 67 Leucovorin 65 Fulvestrant 58 Oxaliplatin 57 durvalumab 56 Trastuzumab 56 Lenalidomide 55 Ipilimumab 55 Midazolam 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × Vancomycin × Clear all

NCT06540391 2025-09-26

MELODY-1

Microbiotica Ltd

Phase 1 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡